FTSE 100 companies put aside a total of £2.69bn to cover the cost of tax litigation in 2016, according to figures compiled by Thomson Reuters. This represents a 62% increase over 2015.
Pharmaceutical companies set aside the most, making provisions of £1.67bn (64% of the total).
FTSE 100 companies put aside a total of £2.69bn to cover the cost of tax litigation in 2016, according to figures compiled by Thomson Reuters. This represents a 62% increase over 2015.
Pharmaceutical companies set aside the most, making provisions of £1.67bn (64% of the total).
FTSE 100 companies put aside a total of £2.69bn to cover the cost of tax litigation in 2016, according to figures compiled by Thomson Reuters. This represents a 62% increase over 2015.
Pharmaceutical companies set aside the most, making provisions of £1.67bn (64% of the total).
FTSE 100 companies put aside a total of £2.69bn to cover the cost of tax litigation in 2016, according to figures compiled by Thomson Reuters. This represents a 62% increase over 2015.
Pharmaceutical companies set aside the most, making provisions of £1.67bn (64% of the total).
